Special Issue "Antiparasitics"
Deadline for manuscript submissions: closed (15 June 2021).
Interests: drug design; parallel synthesis; anti-infective drugs; natural products; antivirals
Special Issues and Collections in MDPI journals
Special Issue in Pharmaceuticals: Advances in Pharmaceutical Sciences
Parasitic infections affect more than two billion people worldwide and account for significant morbidity and mortality throughout the world. Antiparasitic drugs are the main therapeutic treatment, but like most drugs, they have many side effects, and the risk of resistance is always a concern. Furthermore, the enormous suffering and loss of productivity translate on a large financial burden for a population that already has limited resources. Many of the parasitic diseases are considered neglected tropical diseases (NTDs) as established by the World Health Organization (WHO). Most of the current antiparasitic drugs represent no financial return on investment for the pharmaceutical industry. Indeed, the development of new or novel antiparasitic drugs have been characterized by a lack of investment from the private sector and low attention from public health.
Despite the low financial return, there is a need for novel chemical entities with a new antiparasitic mechanism of action. In this Special Issue of Pharmaceuticals, we welcome both reviews and original research articles focused on the discovery and development of new antiparasitic drugs. The proposed topics include but are not limited to:
- Validation of new targets;
- New chemical entities with antiparasitic activity;
- Natural products;
- Novel strategies for the discovery and development of antiparasitic drugs;
- Mechanism of resistance.
Prof. Dr. Marcelo J. Nieto
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antiparasitic drugs
- parasite resistance
- small molecules
- drug discovery